copd Archives - Business Intelligence

Tag: copd

IR13

Market Analysis Helps a Renowned COPD Drugs Manufacturer Quickly Respond to Business Issues and Opportunities

Due to the rising instances of diseases across the globe, it has become indispensable for organizations to offer promising healthcare solutions to reduce health complications. More like smoker’s cough, the chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease, which causes obstruction in the airflow to the lungs. Also, with the lack of health literacy among the populace, people with the COPD can only be diagnosed once the disease has advanced. With a considerable number of the population being infected by the disease, renowned drug manufacturers in the COPD space are facing the need to reduce inflammation and improve patient health outcomes. Moreover, to enter a market space and outline the prevalence rates of COPD, leading drugs manufacturers are facing the need for an effective market analysis study. Market analysis, helps drugs manufacturers profile various customer segments and buying patterns and understand the economic environment in terms of the barriers to entry and regulation.

With the help of Infiniti’s market analysis solution, drugs manufacturers in the pharmaceuticals market space can identify the attractiveness of the market and the potential bottlenecks hindering the market’s growth.IR_Brochure

The Business Challenge

A renowned COPD drugs manufacturer with a considerable number of manufacturing units spread across the globe was facing predicaments assessing the demand and supply for their products. The COPD drugs manufacturer wanted to tap potential opportunities in the market and penetrate across niche market segments. Furthermore, with the aid of market analysis, the COPD drugs supplier wanted to gain relevant insights on the popular treatments and forecast the market’s growth prospects. The primary objective of the engagement was to analyze the market outlook in terms of the competitors and compliance regulations.

IR- market analysis

Want more information about our market analysis solution?
Ask an analyst

Our Approach

To gain detailed insights into the COPD drugs market space, Infiniti’s pharmaceutical experts followed a qualitative and quantitative research methodology. To analyze the shift toward patient engagement, the market analysis experts at Infiniti also compiled information from proprietary sources, including industry databases, company forums, and newsletters.

Market Analysis Solution Benefits:

  • Gained an in-depth analysis of the industry and assessed the potential of new COPD drugs
  • Analyzed the market outlook in terms of the trends and sustainability of the industry
  • Gained a holistic view of the industry in terms of its growth potential
  • Devised a comparative analysis of the competitors and their product positioning
  • Identified potential bottlenecks and devised an effective go-to-market engagement

Benefits of Our Integrated Approach

The market analysis engagement offered by Infiniti offered the client detailed insights into the industry in terms of the size, the growth prospects, and trends prevalent in the COPD drugs market. Moreover, with the aid of this market analysis engagement, the COPD drugs manufacturer was able to profile the most suitable customers and understand the latest innovations taking place in the COPD drugs market.

A must-read case study for strategy experts and decision makers looking to target potential markets in the healthcare industry.

IR_RFP

Related Articles:

solar panel manufacturers

COPD – Major Health Problem in Europe, Strike it Out With NIV!

COPD – Chronic obstructive pulmonary disease is expected to increase from almost 270,000 in 2005 to 338,000 deaths by 2030. Often COPD is under diagnosed, inferring that the prevalence rates are only going to increase. Recently, Infiniti Research performed a market assessment on COPD and Non-Invasive Ventilation (NIV) treatment for the European market, and here are some insights from our market assessment for medical device manufacturers specializing in NIV to help them develop effective market entry strategies.

NIV to Witness Robust Growth

A recent market assessment study shows that COPD is the major cause of death, whose prevalence is on the rise and is envisaged to be the third leading cause of death globally by 2030. Furthermore, patients getting affected are on the aging side; as a result of which, physicians prefer non-invasive techniques over the invasive ones. The recent rise in chronic respiratory diseases has increased the demand for the right medical device supplies. Since the market witnesses a surge in the popularity of ventilators our industry experts feel that this would be the right time for the medical device manufacturers to take a plunge in this industry. Other than COPD, NIV has also been successfully used in patients with acute respiratory distress syndrome (ARDS) and postoperative and post-transplantation respiratory failure, reducing intubation rates, ICU stays, and the overall mortality rate.

Recent Developments and Opportunities

The advantages that NIV treatment offers is tremendous. One of the key areas for the vendors in Europe to target is the private sector. With medical device reimbursement getting strict, NIV has the edge over the other treatments and the reimbursement guidelines look promising. This trend is catching up and is sure to prevail in the UK as well. Our market assessment was focused at countries such as the UK, France, Italy, Germany, Spain, Sweden, Norway, Switzerland, Denmark, Portugal, and Finland. A research on first-line NIV treatment was associated with a decrease in 60-day mortality rate from 27 to 9% throughout the study period. The incidence of increasing chronic respiratory diseases and NIV treatment reducing the mortality rate shows the perfect balance in the medical device industry.

The Futuristic View of NIV Treatment

Other than the private sector, if you’re an NIV treatment vendor, home care ventilation is another booming sector to watch out for.  Most of the patients suffering from COPD are suggested home ventilation by the physicians, thus, leading to the reduction in the length of stays in hospitals. Tapping the home care market will ensure high returns when it comes to home care ventilation. Not just that, with the high risk associated with hospital-acquired infections, home care ventilators are a great choice to stay safe and healthy.

How We Help in Smarter Decision Making

Being the preferred partner for more than 55 Fortune 500 firms, we can help any leading global respiratory device manufacturer make the right decision about exploring the untapped sectors. In a recent market assessment engagement, we helped a global pharmaceutical conglomerate evaluate the prevalence and magnitude of COPD and global initiative for chronic obstructive lung disease (GOLD) across 10 European countries. During the course of this research, it was found that with the growing rate of COPD, sleep apnoea, and other respiratory disease, the usage of NIV treatment in both hospitals and home care segment is sure to go sky high.

Here is a successful market assessment case study on how we helped a leading global respiratory health products manufacturer make the right decision when it comes to market entry. You can read the complete case study here!

product research

Market Opportunity Assessment and Healthcare Information Mapping on COPD and NIV Treatment Across Europe

Every hour, COPD is estimated to kill over 250 people worldwide. The WHO estimates that COPD will be the third leading cause of death globally by 2030.

 

More like a ‘smoker’s cough,’ the chronic obstructive pulmonary disease (COPD) is a life-threatening lung disease that interferes with normal breathing. A recent study shows that it is the only major cause of death whose prevalence is on the increase and is envisaged to be the third leading cause of death globally by 2030 – exceeded only by heart diseases and stroke. This recent increase in the incidence of COPD in regions like the Europe has subsequently accelerated the need for treatment options like Non-Invasive Ventilation (NIV), which help patients breathe through a machine that is attached to a mask. Though similar to a nebulizer, NIV is usually used when patients have a severe flare-up of their breathing problem.

For companies in the medical devices sector, this recent outburst in the incidence of COPD presents a goodcapture opportunity to plan for market entry and take advantage of the emerging high demand for various treatment options. However, entering a market space that is rapidly becoming competitive is no simple feat due to the limited availability of statistical information and prevalence rate for COPD. Also, the lack of concrete information on the price-rate variation for COPD and NIV treatment will pose a significant challenge for most medical devices manufacturers looking to enter or expand their market share in this space.

The Business Challenge

To assess the changing demand-supply landscape of the COPD and NIV treatment market across Europe, a leading global respiratory device manufacturer approached Infiniti to obtain effective healthcare information mapping and insights on emerging and untapped market opportunities which they can target.

The primary goal of this market opportunity assessment and healthcare information mapping engagement was to evaluate the prevalence and magnitude of COPD and global initiative forcapture2 chronic obstructive lung disease (GOLD) across 10 European countries. Additionally, the healthcare information mapping service also offered insights on popular treatment patterns to assess the potential for their devices across specific set of target countries such as the UK, France, Italy, Germany, Spain, Sweden, Norway, Switzerland, Denmark, Portugal, and Finland.

Infiniti’s experienced healthcare information mapping and market opportunity assessment team tracked recent developments and innovations in the market through secondary journals and reached out to relevant stakeholders such as industry experts, KOLs, device users, procurement experts to understand their views on market. Our healthcare information mapping and market opportunity assessment research team also spoke to stakeholders responsible for sales and distribution of these devices to understand how the market would grow in short and long term and also to validate market size and opportunity model developed for this segment.

Why Infiniti Research is the preferred partner for more than 55 Fortune 500 Companies

untitled

Solution Offered and Impact

By evaluating a wide array of published literature to develop an initial hypothesis, Infiniti’s industry experts identified numerous market stakeholders and conducted in-depth primary and secondary research to determine the prevalence, prescription patterns, key treatment methods used, and new trends affecting the COPD treatment in Europe. The research team also conducted a large number of interviews and discussions with major market stakeholders to obtain information specific to the market.

In just eight weeks, our healthcare experts helped the client gain strategic insights into the prevalence of COPD and GOLD in Europe along with an analysis of latest developments and innovations in this space.

To assess the challenges specific to the healthcare medical devices sector, Infiniti’s healthcare experts have developed an extensive proprietary database consisting of information on more than two million industry experts, doctors, physicians, key opinion leaders, medical technicians, payers, end-users, and patients. This database also includes high quality and accurate information obtained through quantitative and qualitative surveys with effective response rate. We also have a collection of the best-in-class global network of 3000+ payers influencers, and KOLs spread across multiple channels in 50+ countries.

What do the clients appreciate about our approach?

In a relatively short period of time, just eight weeks, the client saw clear benefits from our relationship. The benefit was not only in terms of revenue impact or analytics turnaround time but also in terms of the experience we were staging for them by exposing them to a new way of problem-solving.

Here are some of the key points appreciated by our clients

 

  • Dedicated Market Intelligence Portal. A centralized platform for the collection, storing, processing, reporting, and dissemination of information with the specific purpose of assisting the decision-making process and developing actionable insights. This portal includes comprehensive information on quantitative and qualitative aspects on target markets, competitors and end-users.
  • Collaborative learning. We leveraged experience of our healthcare team and our technical capabilities to enable report-sharing and other collaborative features appreciated by client teams.
  • Database Access. Access to a patient database containing information about 60+ medical diseases and conditions, such as patient undergoing treatment, untreated patients, and patients with chronic conditions.
  • Interactive Dashboard. Using our Portal based solution for healthcare professionals, we took a design-first approach to problem solving and helped break through previously held assertions.
  • Value for Money. Infiniti’s dedicated client management team customizes reports to suit business requirements and offers the best insights for every dollar spent.

 

A must-read case study for strategy experts and decision makers looking for effective market opportunity assessment and healthcare information mapping services.

 

 

Request your free proposal now

 

Related reports:

 

COPD and NIV Treatment Across Europe

To read more about COPD, click here.

Close
Infiti Logo

Hello there!

Contact us to know more about our cost-effective custom market research offerings to support efficient market penetration, new product launch, and devise strategies to monitor and outperform your competitors.

Cookie Policy

The Site uses cookies to record users' preferences in relation to the functionality of accessibility. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice